APPLICATIONS PUBLISHED 2 MARCH 2005
Published: 1-Mar-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Dry powder inhalant compsn
Glaxo Group 1509199*
Film-shaped, dissolvable preparations for active substance release and method for the production thereof
LTS Lohmann Therapie-Systeme 1509200*
Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof
LTS Lohmann Therapie-Systeme 1509201*
Novel high-viscosity embolising compsns comprising prepolymers
Micro Therapeutics 1509202*
Delivery of nucleic acid-like compounds
California Pacific Medical Centre 1509203*
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
Penwest Pharmaceutical 1509204*
Pharmaceutical compsn having a delayed active substance release, and method for the preparation thereof
Desitin Arzneimittel 1509205*
A haemostatic compsn
Materials Modification 1509206*
Pharmaceutical compsn containing oxcarbazepine and having a controlled active substance release
Desitin Arzneimittel 1509207*
Hydrodynamically balancing oral drug delivery system with biphasic release
Ranbaxy Laboratory 1509208*
Compsns and method for transmucosal drug delivery and cryoprotection
UMD 1509209*
Plaster containing fentanyl
Labtec Gesellschaft fuer Technologische Forschung und Entiwicklung 1509210*
Solubilisation of drugs in HFA propellant by means of emulsions
Cheisi Farmaceutici 1509211*
Novel chromium (III) alpha amino acid complexes
Zinpro 1509212*
Acetamides and benzamides that are useful in treating sexual dysfunction
Abbott Laboratories 1509213*
Infant formula compsns containing lutein and zeaxanthin
Wyeth 1509214*
Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
Hormos Medical Corp 1509215*
Active ingredient salts and esters of 1-dimethylamino-3(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
Gruenenthal 1509216*
Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX 2) inhibitor(s)
Pharmacia 1509217*
Peptide deformylase inhibitors
SmithKline Beecham 1509218*
Methods and compsns for the treatment of graft failure
Beth Israel Deaconess Medical Centre 1509219*
A pharmaceutical compsn for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4,2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl)-1-oxaspiro-2,5)octane-6-one
Mycoplus 1509220*
N-acylaminoacetonitrile derivatives and their use for controlling parasites
Novartis 1509221*
Adduct of topiramate and tramadol hydrochloride and uses thereof
Cilag 1509222*
Hepatoprotective activity of 10-O-P-hydroxybenzoylaucubin
Council of Scientific and Industrial Research 1509223*
Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
Pharmacia 1509224*
Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
Wyeth 1509225*
Small molecule inhibitors of HER2 expression
Baylor College of Medicine 1509226*
A buffered, liquid nicotine compsn for pulmonary administration
Pfizer 1509227*
Derivatives of 2-(1-benzyl)-1H-pyrazolo (3,4-B)pyridine-3-yl)-5(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
Bayer Healthcare 1509228*
Compsns comprising hepoxilin analogues and their use in the treatment of cancer
The Hospital for Sick Children 1509229*
Method for treating cancer using kinase inhibitors
Cedars-Sinai Medical Centre 1509230*
Peritoneal dialysis solution with taurolidine
ND Partners 1509231*
A combination of an NMDA-antagonist and acetylcholine-esterase inhibitors for the treatment of Alzheimer's disease
H Lundbeck 1509232*
Liquid formulation of decitabine and use of the same
SuperGen 1509233*
Treatment of mucositis
Abbott Laboratories 1509234*
Method for the protection of endothelial and epithelial cells during chemotherapy
Klinikum der Universitaet Regensburg 1509235*
Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions
Children's Hospital of Los Angeles 1509236*
Methods of treating angiogenesis, tumours growth and metastatsis
Yale University; University of Pittsburgh of the Commonwealth System of Higher Education 1509237*
Calcium-containing compsn from bone tissue
Geraldine Smits Beheer 1509238*
Compsn and method for reducing post-prandial blood glucose
Kemin Consumer Care 1509239*
Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases
University of Florida Research Foundation 1509240*
Novel use of cephaibols
Aventis Pharma Deutschland 1509241*
Treatment of hepatitis C in the Asian population with subcutaneous interferonbeta
Applied Research Systems 1509242*
Topical drug delivery using phosphatidylcholine
Perricone, Nicholas V 1509243*
New method and compsn for producing a cellular allogeneic vaccine
Immunicum 1509244*
Methods of diagnosing and treating diabetes and insulin resistance
Metabolex 1509245*
Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy
MagnaMedics 1509246*
Use of inhibitors of phospholipase A2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating diseases
McGill University 1509247*
Combination of angiotensin II receptor blockers and beta-blocker for secondary prevention of myocardial infarction
Novartis 1509248*
Inclusion complexes of rosiglitazone
Glaxo Group 1509249*
Methods, compsns and articles of manufacture for modulating bone growth
Yissum Research Development Company of the Hebrew University of Jerusalem 1509250*
Nucleic acids, polypeptides and methods for modulating apoptosis
Senesco Technologies 1509251*
Methods and compsns for correction of cardiac conduction disturbances
The Regents of the University of California 1509252*
Chimeric CD154
The Regents of the University of California 1509253*
New agents for magnetic imagine method
Bracco Imaging 1509254*
Methods and compsns for intravesical therapy of bladder cancer
Immunomedics 1509255*
Short-acting sedative hypnotic agents for anaesthesia and sedation
Theravance 1509492*
Deodorisation of cationic acetonitrile derivatives
Henkel Kommanditgesselschaft auf Aktien 1509493*
Amidoacetonitrile compounds
Novartis 1509494*
Anilino liver X-receptor modulators
Pharmacia 1509495*
Method for producing isocyanates
BASF 1509496*
Calcium receptor modulating arylalylamines
Amgen 1509497*
Pentafluorosulphanyl-benzoyl-guanidine, method for the production thereof and its utilisation as medicament or diagnostic agent and medicament containing same
Aventis Pharma 1509498*
Pyrrole compounds for the treatment of prostaglandin mediated diseases
Glaxo Group 1509499*
Process for the preparation of the amorphous form of atorvastatin calcium salt
Chemi 1509500*
1-(aminoalkyl)-3-sulphonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
Wyeth 1509501*
Method of forming a carbon-carbon or carbon-heteroatom linkage
Rhodia Chimie 1509502*
Iminium salts in cleaning compsns
Procter & Gamble 1509503*
7-phenylsulphonyl-tetrahydro-3-benzapine derivatives as antipsychotic agents
Glaxo 1509504*
Small molecule modulators of the 5-HT2A serotoxin receptor useful for the prophylaxis and treatment of disorders related thereto
Arena Pharmaceuticals 1509505*
Pyridazine derivatives
Merck 1509506*
Mitotis kinesin inhibitors
Merck 1509507*
Selective chromophores
Westman, Gunnar 1509508*
Glucagon antagonists/inverse agonists
Novo Nordisk 1509509*
Epoxidation process using a supported niobium oxide catalyst
ARCO Chemical Technology 1509510*
Antithelminitic and insecticidal thiophene derivatives
Pharmacia & Upjohn 1509514*
Substituted 4-aryl-4H-pyrrolo-2,3-H chromenes and analogues as activators of caspases and inducers of apoptosis and the use thereof
Cytovia; Shire Biochem 1509515*
Inhibitors of the GPIB-VWF interaction, their preparation and use
Aventis Pharma Deutschland; Ajinomoto 1509516*
Novel synthesis of irbesartan
Teva Pharmaceuticals 1509517*
Calcium receptor modulating agents
Amgen 1509518*
Crystalline fluoroquinoline arginine salt
Wockhardt 1509519*
Use of benzo(C)quinolizinium derivatives for the treatment of dieases that are linked to smooth muscle cell construction
Centre National de la Recherche Scientifique 1509520*
1H-imidazo(4m5-C)quinoline derivatives in the treatment of protein kinase dependent diseases
Novartis 1509521*
1-(aminoalkyl)-3-sulphonylazaindoles as 5-hydroxytryptamine-6 ligands
Wyesth 1509522*
Triazaspiro compounds useful for treating or preventing pain
Euroceltique 1509523*
Xanthine phosphodiesterase V inhibitor polymorphs
Schering 1509524*
Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
Schering 1509525*
Imidazo(1,2-A)pyrazin-8-ylamines, method of making, and method of use thereof
Cellular Genomics 1509526*
Preparation of metal mesoprophyrin halide compounds
Wellspring Pharmaceutical 1509527*
1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
Pliva-Istrazivacki Institut 1509528*
Esters in position 20 of camptothecins
Sigma-Tau Industrie Farmaceutiche Riunite 1509529*
2-thia-dibenzoazulenes as inhibitors for tumour necrosis factor production and intermediates for the preparation thereof
Pliva-Istrazivacki Institut 1509530*
Methods for preparation of olanzapine polymorphic form I
Insytut Farmaceutyczny 1509531*
1-thia-3-aza-bibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
Pliva-Istrazivacki Institut 1509532*
Polyol-modified silanes as precursors for silica
McMaster University 1509533*
Compound and processes for the preparation and use thereof
Avecia 1509535*
Fluorinated phosphonic acids
3M Innovative Properties 1509536*
Cellular accumulation of phosphonate analogues of HIV protease inhibitor compounds and the compounds as such
Gilead Sciences 1509537*
6,11-bicyclic eryhtormycin derivatives
Enanta Pharmaceuticals 1509538*
Novel compsns and ehmtods for cancer
Sagres Discovery 1509539*
Claudin polypeptides, polynucleotides, and methods of making and use thereof
Immunex Corp 1509540*
Novel recombinant anticoagulant proteins
Wun, Tze Chein 1509541*
Methods for measuring kinase activity and phosphatase activity
Pharmacopeia 1509542*
Non-immunosuppressive immunogenic or vaccine compsn comprising a mutated E7 protein of the HPV-16 virus
Neovacs 1509543*
CARD-4 molecules and uses thereof
Institut Pasteur 1509544*
Homotrimeric extended OBG3 globular head and uses thereof
Serono Genetics Institute 1509545*
Collagen and method of producing same
Colltech Australia 1509546*
Antibodies to adipose tissues
Walcom Animal Science 1509547*
Method for the production of cellulose carbamate moulded bodies
Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung 1509548*
Extract of unmilled psyllium
Procter & Gamble 1509549*
Polymeric product for film formation
University of Debrecem 1509550*
